STAR-001 (LP-184)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STAR-001 (LP-184), covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression [Phase 1, Phase 2]